Sevoflurane Market Size to Hit USD 2.02 Billion by 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Sevoflurane Market

5.1. COVID-19 Landscape: Sevoflurane Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Sevoflurane Market, By Product Type

8.1. Sevoflurane Market Revenue and Volume, by Product Type

8.1.1. Branded Sevoflurane

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Generic Sevoflurane

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. High-Purity Sevoflurane

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Pediatric Grade Sevoflurane

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Hospital Grade Sevoflurane

8.1.5.1. Market Revenue and Volume Forecast

Chapter 9. Global Sevoflurane Market, By Formulation

9.1. Sevoflurane Market Revenue and Volume, by Formulation

9.1.1. Liquid Sevoflurane

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Stabilized Sevoflurane

9.1.2.1. Market Revenue and Volume Forecast

Chapter 10. Global Sevoflurane Market, By Application

10.1. Sevoflurane Market Revenue and Volume, by Application

10.1.1. General Surgery

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Cardiovascular Surgery

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Orthopedic Surgery

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Neurological Surgery

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Pediatric Surgery

10.1.5.1. Market Revenue and Volume Forecast

10.1.6. Ambulatory Surgery

10.1.6.1. Market Revenue and Volume Forecast

Chapter 11. Global Sevoflurane Market, By End User

11.1. Sevoflurane Market Revenue and Volume, by End User

11.1.1. Hospitals

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Ambulatory Surgical Centers (ASCs)

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Specialty Clinics

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Academic & Research Institutes

11.1.4.1. Market Revenue and Volume Forecast

Chapter 12. Global Sevoflurane Market, By Distribution Channel

12.1. Sevoflurane Market Revenue and Volume, by Distribution Channel

12.1.1. Direct Tender Sales

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Hospital Pharmacies

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Pharmaceutical Distributors

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Online Procurement Platforms

12.1.4.1. Market Revenue and Volume Forecast

Chapter 13. Global Sevoflurane Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product Type

13.1.2. Market Revenue and Volume Forecast, by Formulation

13.1.3. Market Revenue and Volume Forecast, by Application

13.1.4. Market Revenue and Volume Forecast, by End User

13.1.5. Market Revenue and Volume Forecast, by Distribution Channel

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product Type

13.1.6.2. Market Revenue and Volume Forecast, by Formulation

13.1.6.3. Market Revenue and Volume Forecast, by Application

13.1.6.4. Market Revenue and Volume Forecast, by End User

13.1.6.5. Market Revenue and Volume Forecast, by Distribution Channel

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product Type

13.1.7.2. Market Revenue and Volume Forecast, by Formulation

13.1.7.3. Market Revenue and Volume Forecast, by Application

13.1.7.4. Market Revenue and Volume Forecast, by End User

13.1.7.5. Market Revenue and Volume Forecast, by Distribution Channel

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product Type

13.2.2. Market Revenue and Volume Forecast, by Formulation

13.2.3. Market Revenue and Volume Forecast, by Application

13.2.4. Market Revenue and Volume Forecast, by End User

13.2.5. Market Revenue and Volume Forecast, by Distribution Channel

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product Type

13.2.6.2. Market Revenue and Volume Forecast, by Formulation

13.2.6.3. Market Revenue and Volume Forecast, by Application

13.2.7. Market Revenue and Volume Forecast, by End User

13.2.8. Market Revenue and Volume Forecast, by Distribution Channel

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product Type

13.2.9.2. Market Revenue and Volume Forecast, by Formulation

13.2.9.3. Market Revenue and Volume Forecast, by Application

13.2.10. Market Revenue and Volume Forecast, by End User

13.2.11. Market Revenue and Volume Forecast, by Distribution Channel

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product Type

13.2.12.2. Market Revenue and Volume Forecast, by Formulation

13.2.12.3. Market Revenue and Volume Forecast, by Application

13.2.12.4. Market Revenue and Volume Forecast, by End User

13.2.13. Market Revenue and Volume Forecast, by Distribution Channel

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product Type

13.2.14.2. Market Revenue and Volume Forecast, by Formulation

13.2.14.3. Market Revenue and Volume Forecast, by Application

13.2.14.4. Market Revenue and Volume Forecast, by End User

13.2.15. Market Revenue and Volume Forecast, by Distribution Channel

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product Type

13.3.2. Market Revenue and Volume Forecast, by Formulation

13.3.3. Market Revenue and Volume Forecast, by Application

13.3.4. Market Revenue and Volume Forecast, by End User

13.3.5. Market Revenue and Volume Forecast, by Distribution Channel

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product Type

13.3.6.2. Market Revenue and Volume Forecast, by Formulation

13.3.6.3. Market Revenue and Volume Forecast, by Application

13.3.6.4. Market Revenue and Volume Forecast, by End User

13.3.7. Market Revenue and Volume Forecast, by Distribution Channel

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product Type

13.3.8.2. Market Revenue and Volume Forecast, by Formulation

13.3.8.3. Market Revenue and Volume Forecast, by Application

13.3.8.4. Market Revenue and Volume Forecast, by End User

13.3.9. Market Revenue and Volume Forecast, by Distribution Channel

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product Type

13.3.10.2. Market Revenue and Volume Forecast, by Formulation

13.3.10.3. Market Revenue and Volume Forecast, by Application

13.3.10.4. Market Revenue and Volume Forecast, by End User

13.3.10.5. Market Revenue and Volume Forecast, by Distribution Channel

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product Type

13.3.11.2. Market Revenue and Volume Forecast, by Formulation

13.3.11.3. Market Revenue and Volume Forecast, by Application

13.3.11.4. Market Revenue and Volume Forecast, by End User

13.3.11.5. Market Revenue and Volume Forecast, by Distribution Channel

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product Type

13.4.2. Market Revenue and Volume Forecast, by Formulation

13.4.3. Market Revenue and Volume Forecast, by Application

13.4.4. Market Revenue and Volume Forecast, by End User

13.4.5. Market Revenue and Volume Forecast, by Distribution Channel

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product Type

13.4.6.2. Market Revenue and Volume Forecast, by Formulation

13.4.6.3. Market Revenue and Volume Forecast, by Application

13.4.6.4. Market Revenue and Volume Forecast, by End User

13.4.7. Market Revenue and Volume Forecast, by Distribution Channel

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product Type

13.4.8.2. Market Revenue and Volume Forecast, by Formulation

13.4.8.3. Market Revenue and Volume Forecast, by Application

13.4.8.4. Market Revenue and Volume Forecast, by End User

13.4.9. Market Revenue and Volume Forecast, by Distribution Channel

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product Type

13.4.10.2. Market Revenue and Volume Forecast, by Formulation

13.4.10.3. Market Revenue and Volume Forecast, by Application

13.4.10.4. Market Revenue and Volume Forecast, by End User

13.4.10.5. Market Revenue and Volume Forecast, by Distribution Channel

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product Type

13.4.11.2. Market Revenue and Volume Forecast, by Formulation

13.4.11.3. Market Revenue and Volume Forecast, by Application

13.4.11.4. Market Revenue and Volume Forecast, by End User

13.4.11.5. Market Revenue and Volume Forecast, by Distribution Channel

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product Type

13.5.2. Market Revenue and Volume Forecast, by Formulation

13.5.3. Market Revenue and Volume Forecast, by Application

13.5.4. Market Revenue and Volume Forecast, by End User

13.5.5. Market Revenue and Volume Forecast, by Distribution Channel

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product Type

13.5.6.2. Market Revenue and Volume Forecast, by Formulation

13.5.6.3. Market Revenue and Volume Forecast, by Application

13.5.6.4. Market Revenue and Volume Forecast, by End User

13.5.7. Market Revenue and Volume Forecast, by Distribution Channel

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product Type

13.5.8.2. Market Revenue and Volume Forecast, by Formulation

13.5.8.3. Market Revenue and Volume Forecast, by Application

13.5.8.4. Market Revenue and Volume Forecast, by End User

13.5.8.5. Market Revenue and Volume Forecast, by Distribution Channel

Chapter 14. Company Profiles

14.1. Baxter International

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. AbbVie Inc. (Legacy Allergan Anesthesia Portfolio)

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Piramal Pharma Limited

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Halocarbon Life Sciences

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Lunan Pharmaceutical Group

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Maruishi Pharmaceutical Co., Ltd.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Jiangsu Hengrui Pharmaceuticals Co., Ltd.

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. PENN Pharmaceutical Services Ltd.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Piramal Critical Care

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Nichi-Iko Pharmaceutical Co., Ltd.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The sevoflurane market size is expected to increase from USD 1.15 billion in 2025 to USD 2.02 billion by 2035.

Answer : The sevoflurane market is expected to grow at a compound annual growth rate (CAGR) of around 5.80% from 2026 to 2035.

Answer : The major players in the sevoflurane market include Baxter International, AbbVie Inc. (Legacy Allergan Anesthesia Portfolio), Piramal Pharma Limited, Halocarbon Life Sciences, Lunan Pharmaceutical Group, Maruishi Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., PENN Pharmaceutical Services Ltd., Piramal Critical Care, Nichi-Iko Pharmaceutical Co., Ltd., Sandoz Group AG, Mylan (Viatris), Fresenius Kabi AG, Troikaa Pharmaceuticals Ltd., and Rusan Pharma Ltd.

Answer : The driving factors of the sevoflurane market are the increasing healthcare expenditure, expansion of ambulatory surgical centers, rising prevalence of chronic diseases requiring surgical intervention, and advancements in anesthesia delivery systems are driving market growth.

Answer : North America region will lead the global sevoflurane market during the forecast period 2026 to 2035.